PBMs have evaded lawmakers’ reform attempts so far. Could 2025 turn the tide?
PharmaVoice
JANUARY 6, 2025
How regulators could hit PBMs from multiple sides in the coming year.
PharmaVoice
JANUARY 6, 2025
How regulators could hit PBMs from multiple sides in the coming year.
MedCity News
JANUARY 8, 2025
Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of programs covered under the agreement. The post Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagships Valo Health appeared first on MedCity News.
PharmaTimes
JANUARY 6, 2025
IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer
European Pharmaceutical Review
JANUARY 7, 2025
The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
JANUARY 7, 2025
The FDA has placed the credibility of AI's 'context of use' in pharma development at the heart of its first guidance in this area
MedCity News
JANUARY 8, 2025
Galapagos said the planned business separation will leave the legacy company free to focus on developing cell therapies for cancer. An accompanying corporate restructuring will shave Galapagoss headcount by 40%. The post Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by 2.4B appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaVoice
JANUARY 9, 2025
Candel Therapeutics’ CEO had to prioritize a phase 3 program amid layoffs and cuts, and an end-of-year clinical success was the redemption he was looking for.
pharmaphorum
JANUARY 6, 2025
MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk.
MedCity News
JANUARY 6, 2025
Families USA led a letter urging the new Congress, which was sworn in on Jan. 3, to protect Medicaid. The post Over 300 Organizations Call on New Congress to Safeguard and Strengthen Medicaid appeared first on MedCity News.
Pharmaceutical Commerce
JANUARY 6, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), provides a peek into what the association has set out to accomplish.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
PharmaVoice
JANUARY 8, 2025
A wave of new weight loss treatments is on the way, and drugmakers are scrambling for a foot in the door.
pharmaphorum
JANUARY 6, 2025
Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.
MedCity News
JANUARY 9, 2025
AI offers a number of immediate opportunities for pharmacies to change their operation through intelligent automation, freeing up pharmacists to provide their patient population with higher-value services like patient counseling and medication management. The post What AI Can Do for Pharmacist Burnout appeared first on MedCity News.
PharmaTimes
JANUARY 9, 2025
Groundbreaking approval provides new hope for patients in England and Wales
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmaVoice
JANUARY 10, 2025
Coming changes that could impact pharma from drug development to launch.
pharmaphorum
JANUARY 9, 2025
Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.
MedCity News
JANUARY 9, 2025
Verdiva Bios once-a-week oral GLP-1 drug is ready for Phase 2 testing. The drug, made with a proprietary technology that enables oral dosing, was licensed from Sciwind Biosciences. The post Metabolic Meds Startup Verdiva Launches With $411M and a Weekly Oral GLP-1 Drug appeared first on MedCity News.
PharmaTimes
JANUARY 6, 2025
EpiSwitch PSE shows promise in reducing unnecessary procedures
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
ALULA
JANUARY 9, 2025
Outsmart your brain & achieve goals! Learn how to leverage your brain's neural network with powerful prompts. Environmental, digital, social, & emotional cues for lasting change.
pharmaphorum
JANUARY 9, 2025
A new obesity start-up Verdiva Bio has just decloaked with a whopping $411m to advance a once-weekly oral GLP-1 agonist.
MedCity News
JANUARY 8, 2025
Certified clinicians and therapists have specific ethical foundations and analytic responsibilities to uphold that might not apply to all members of the healthcare field. The post Understanding the Ethics of AI in ABA Therapy appeared first on MedCity News.
PharmaTimes
JANUARY 8, 2025
Investment to support RNA therapeutics for epilepsy and neurological disorders
ALULA
JANUARY 9, 2025
Behavior-hack your way to success! Final installment. Learn the POWER Framework: Plan, Observe, Work, Evaluate, Repeat. Fun experiments to improve work & life.
pharmaphorum
JANUARY 10, 2025
Ouro launches today with $120m in funding and a plan to develop bispecific antibody-based T cell engagers for autoimmune diseases.
MedCity News
JANUARY 8, 2025
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO markets return to normal levels. The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on MedCity News.
PharmaTimes
JANUARY 7, 2025
OAV101 IT expands potential for type II SMA patients
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
Pharmaceutical Commerce
JANUARY 7, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), explains why this resource is an asset, specifically for research in the psychedelic space.
pharmaphorum
JANUARY 9, 2025
Pharma groups have called for EU adoption of electronic product information (ePI) to take place within four years in a new position paper.
MedCity News
JANUARY 8, 2025
By grounding wellness programs in behavior-change science, employers can empower their people to build healthier, more sustainable habits. The post Study: Why Quick Fixes Dont Work in Workplace Wellness appeared first on MedCity News.
PharmaTimes
JANUARY 7, 2025
M-Trust set to improve product safety and counterfeiting solutions
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Let's personalize your content